Actively Recruiting
Pilot Study of Personalized Closed Loop Deep Brain Stimulation Using Brain Mapping for Treatment-Resistant Schizophrenia
Led by Bradley Lega · Updated on 2026-06-09
10
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating a new approach for treatment-refractory schizophrenia using next-generation Deep Brain Stimulation DBS combined with stereo electroencephalogram SEEG brain mapping. The study aims to evaluate safety, efficacy, and mechanisms of DBS in altering psychotic brain states using advanced brain classifiers and personalized stimulation protocols. This pilot study addresses the limitations of current treatments for schizophrenia that does not respond to standard therapies. Participants will receive an Abbott Laboratories Infinity implantable deep brain stimulation system. After an open-label period, participants are randomized to one of two groups either initially OFF DBS followed by gradual amplitude increase to ON DBS over eight weeks, or initially ON DBS followed by gradual decrease to OFF DBS over eight weeks. The study uses a randomized sequential design to compare these stimulation schedules and assess brain responses. During the study, participants will undergo brain mapping with SEEG, receive personalized DBS treatment, and be monitored for safety and symptom changes over an extended period. Researchers will measure device safety over three years, psychotic symptom changes, psychosocial function, and cognition. Regular clinic visits, brain imaging, and clinical assessments will support these evaluations, with participants followed for at least 12 months after surgery.
CONDITIONS
Brief Title
Deep Brain Stimulation for Psychosis
Research Team
H
Hila Abush Segev, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here